Home / DAY ONE BIOPHARMACEUTICALS, INC. (DAWN)

Updated: 2026-03-17 00:34 UTC · Last close: 21.36 (+0.23%)

DAY ONE BIOPHARMACEUTICALS, INC. (DAWN) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.

DAY ONE BIOPHARMACEUTICALS, INC. (DAWN) finished the session at 21.36 (+0.23%). Broadly speaking, trend structure still looks constructive because price remains above both the 50-day and 200-day averages. 20-day momentum is notably strong at +88.19%; price is trading in the upper part of its roughly 52-week range (5.80–21.36); and ATR14 volatility is elevated at roughly 5.38% of price. RSI(14) stands near 82.7, suggesting strong bullish momentum with conditions becoming somewhat extended. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD is positioned above the signal line, supporting a still constructive momentum backdrop. The MACD histogram remains positive, although upside momentum is not accelerating further. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. On the downside, 13.36 is the first support area. Holding above it helps keep the current structure more stable. On the fundamentals side, the latest snapshot shows Revenue: 158.18M · Net income: -107.32M · EPS (basic): -1.04. For a fuller technical read, the interactive view adds overlays, pattern context and broader chart structure.

OPEN FULL INTERACTIVE ANALYSIS

Note: This is an algorithmic technical snapshot (not financial advice).

DAWN Chart